Founder and CEO of Tevogen, Ryan Saadi, personally funds the build-out and first-year operations of the company’s new expanded headquarters in Warren, NJ. The new facility doubles the previous footprint and centralizes cross-functional teams, including research, regulatory affairs, and the Tevogen.AI initiative. The completion of the headquarters was ahead of schedule, with a formal ribbon-cutting ceremony planned to celebrate. Tevogen also disclosed forward-looking statements regarding its growth plans, product development, and potential challenges in the healthcare and biopharmaceutical industries. Investors are cautioned to consider these risks and uncertainties before making investment decisions.

Read more at GlobeNewswire: Tevogen’s New Headquarters, Fully Funded by CEO,